Bristol-Myers Squibb Company (BMY): Price and Financial Metrics
Bristol-Myers Squibb Company (BMY)
Today's Latest Price: $59.69 USD
Updated Aug 5 6:40pm
Add BMY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 215 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
BMY Stock Summary
- BMY has a higher market value than 98.73% of US stocks; more precisely, its current market capitalization is $134,562,159,730.
- With a year-over-year growth in debt of 676.36%, Bristol Myers Squibb Co's debt growth rate surpasses 97.22% of about US stocks.
- In terms of volatility of its share price, BMY is more volatile than only 1.74% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to Bristol Myers Squibb Co, a group of peers worth examining would be BIIB, ON, FF, RBBN, and ABUS.
- BMY's SEC filings can be seen here. And to visit Bristol Myers Squibb Co's official web site, go to www.bms.com.
BMY Stock Price Chart Technical Analysis Charts
BMY Price/Volume Stats
| Current price | $59.69 | 52-week high | $68.34 |
| Prev. close | $59.47 | 52-week low | $45.00 |
| Day low | $59.41 | Volume | 10,789,000 |
| Day high | $60.38 | Avg. volume | 15,211,168 |
| 50-day MA | $58.88 | Dividend yield | 3.02% |
| 200-day MA | $59.93 | Market Cap | 135.06B |
Bristol-Myers Squibb Company (BMY) Company Bio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.
Loading social stream, please wait...